HIV-prevention drug to be available for $40 a year from 2027
France 24 · Just In
France 24
Just In
Infectious disease experts have hailed a move that will see a highly effective HIV prevention drug be sold at just 40 dollars a year in low- and middle-income countries. Deals with Indian drug manufacturers will see generic versions of the highly effective lenacapavir rolled out in 120 countries as of 2027.
Breakdown
- Lenacapavir, a twice-yearly HIV-prevention injection, will be available for $40 a year. 6s
- Generic versions will be sold in over 100 countries from 2027 after deals with Indian pharmaceutical companies. 9s
- Lenacapavir reduces the risk of HIV transmission by more than 99.9%. 37s
- The drug currently costs about $28,000 a year in the United States. 51s
- Global efforts have reduced new HIV infections by 40% since 2010, but 1.3 million people contracted HIV in 2024. 1m 20s